T2DM with overt acute/chronic complications,

serum potassium ≥ 5.5 mmol/l,

estimated Glomerular Filtration Rate (eGFR) calculated using the Modification of Diet in Renal Disease formula ≤ 30 ml/min/1.73m² of body weight,

absolute contraindication to any of the drug regimen of the trial,

and current aldosterone antagonist treatment or cessation within the last 15 months

Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension